Hi Friends,

Even as I launch this today ( my 80th Birthday ), I realize that there is yet so much to say and do. There is just no time to look back, no time to wonder,"Will anyone read these pages?"

With regards,
Hemen Parekh
27 June 2013

Now as I approach my 90th birthday ( 27 June 2023 ) , I invite you to visit my Digital Avatar ( www.hemenparekh.ai ) – and continue chatting with me , even when I am no more here physically

Friday, 18 September 2020

A Nightmare come true ?

 


Covid is bad : Black-marketing ( through hoarding of limited supply ) of Vaccine is worse

Context :

Rich countries snap up half of Covid-19 vaccine supply

Extract :

Ø  The five leading vaccine candidates in late-stage trials will be able to supply 5.9 billion doses, enough to inoculate about three billion people, the Oxfam report said. Some 51% of those jabs have been snapped up by the wealthy world, including the US, Britain, the EU, Australia, Hong Kong and Macau, Japan, Switzerland and Israel.

Ø  A study released by Oxfam showed a group of wealthy countries representing just 13% of the world population has secured the lion’s share of doses.

Ø  Access to a life-saving vaccine shouldn’t depend on where you live or how much money you have,” said Robert Silverman of Oxfam America. “Covid-19 anywhere is Covid-19 everywhere.”

=====================================================

What is happening at the “ World Level “, could well happen at the “ National Level “, with the RICH and POWERFUL people of India cornering most of the supplies of locally manufactured ( or even imported SPUTNIK V from Russia ) vaccines

Also consider this : 

India is claimed to be manufacturing 60 % of the total vaccine production of the entire world ( with allegedly , SERUM INSTITUTE – Pune supplying 50 % of world supply )

That imposes on India, a MORAL RESPONSIBILITY to help out poor / covid affected countries, who do not have their own manufacturing facilities, nor the money to import expensive vaccines made by US-EU etc

At the “ World level “, we cannot dictate other countries what distribution regulation they should adopt

But, nothing stops Central Government from announcing the following RULES for the Indian Vaccine Manufacturers :

Ø  You will email ( to DCGI – Drug Controller General of India / ICMR and the Commerce Ministry ), your weekly / monthly, production / sales figures ( including any vaccines imported in bulk for re-packaging or as vials )

 

Ø  You can locally sell vaccine, only to the Central and State Governments (- their notified agencies ) under BULK PURCHASE CONTRACTS

 

 

Ø  In any given month, you will be allowed to EXPORT, 20 % of the dozes that you have actually “delivered “to local governments during the preceding month. For such exports, you will need to apply – and obtain from the Commerce Ministry – an EXPORT LICENCE ( If you have delivered 10 lakh dozes locally in Nov 2020 , you will be issued an export license for exporting 2 lakh dozes in Dec 2020 )

Ø  To get an Export License, you will need to mention the DESTINATION PORTS ( countries to which exporting ). Commerce Ministry will want to ascertain that you are going to export to “ COVID affected POOR countries “ – and not to RICH countries

 

That leaves the question re:

“ Who (which individuals, in which Section-Strata- Region of our society ), shall the Central + State Governments give priority for getting vaccinated ?

How will these priorities get determined systemically – scientifically – transparently ( without introduction of HUMAN BIAS in the process ) ? “

For such a process , read :

Rationing of Covid Vaccine ?   ……………………………………………………[ 06 July 2020 ]

 

Related Readings :

 

“ Corona Kavach “ Insurance  ………………………………………………….[ 07 July 2020 ]

 

An Appeal to DCGI – and others  ……………………………………………..[ 09 July 2020 ]

 

Thank You All   …………………………………………………………………………..[ 10 July 2020 ]

 

Probabilities  ………………………………………………………………………………..[ 19 July 2020 ]

 

Congratulations , Sid Chakravarthy  ………………………………………….[ 24 July 2020 ]

 

Thank You , Cabinet Secretary   ………………………………………………..[ 07 Aug 2020 ]

 

=========================================================================

For the attention of :

Ø  Shri V G Somani, Drug Controller General of India ( DCGI )

    dci@nic.in  /  se.reddy@nic.in 

Ø  The Central Drugs Standard Control Organization ( CDSCO )

     arunsharma@csco.nic.in  /  pbn.prasad@cdsco.nic.in  / bangaru@cdsco.nic.in

Ø  Smt  Shubhra Singh ,

     Chairperson , The National Pharmaceutical Pricing Authority of India ( NPPA )

    Chairman.nppa@nic.in

Ø  Dr T P Lahane, Directorate of Medical Education and Research ( DMER )

     dmerps@gmail.com  /  dmercetcell@gmail.com

Ø  Shri Anil Deshmukhji , (Home Minister , Maharashtra )

         info@anildeshmukh.com / deshmukhv09@gmail.com 

Ø  Shri Rajendra Shinganeji, (FDA Minster , Maharashtra )

         drrajendrashingane61@gmail.com 

Ø  Shri Arun Unhaleji ( FDA Commissioner, Maharashtra )

         comm.fda-mah@nic.in 

Ø  Shri Nandan Nilekani  

    nandan@nandannilekani.in /  nandan_mn@infosys.com 

Ø  Shri Kris Gopalkrishnan  

    accelerator@axilor.com  /   krish@axilor.com  

 

==========================================================================

 

With regards,

Hemen Parekh  /  hcp@rcruitGuru.com  /  18  Sept  2020

 

 

 

 

 

No comments:

Post a Comment